abstract |
The present invention provides the use of an adenosine 5′-phosphosulphate compound or a physiologically tolerable ester or salt thereof, especially a compound of formula In n (wherein X represents a phosphate or hydroxyl group) or an ester or salt thereof, in inhibiting neovascularisation. |